共 14 条
[1]
Correlation of dosimetric factors and radiation pneumonitis for non–small-cell lung cancer patients in a recently completed dose escalation study.[J].Ellen D. Yorke;Andrew Jackson;Kenneth E. Rosenzweig;Louise Braban;Steven A. Leibel;C. Clifton Ling.International Journal of Radiation Oncology; Biology; Physics.2005, 3
[2]
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2005, 61 (05)
:1355-1363
[3]
Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung carcinoma.[J].Jeffrey Bradley;Mary V. Graham;Kathryn Winter;James A. Purdy;Ritsuko Komaki;Wilson H. Roa;Janice K. Ryu;Walter Bosch;Bahman Emami.International Journal of Radiation Oncology; Biology; Physics.2005, 2
[4]
Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review.[J].George Rodrigues;Michael Lock;David D'Souza;Edward Yu;Jake Van Dyk.Radiotherapy and Oncology.2004, 2
[5]
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2003, 55 (01)
:110-115
[6]
Comparing different NTCP models that predict the incidence of radiation pneumonitis
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2003, 55 (03)
:724-735
[8]
Dosis-Volumen-Histogramm-Analyse zum Pneumonitisrisiko bei 3-D-konformaler Strahlentherapie im Bereich der Lunge.[J].Jochen Willner;Andre Jost;Kurt Baier;Michael Flentje.Strahlentherapie und Onkologie.2003, 8
[9]
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2002, 54 (02)
:329-339
[10]
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor β
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2001, 50 (04)
:899-908

